Publication | Closed Access

Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins

Autoimmune DiseaseAllogeneic Myeloma CellsImmunologyPathologyEffective Tumor AntigenAntigen ProcessingAutoimmunityImmunomodulationImmunotherapyMedicineCell TransplantationMyeloma Patients